- Home
- QQQX vs ARDX Comparison
QQQX vs ARDX Comparison
Compare QQQX & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QQQX
- ARDX
- Stock Information
- Founded
- QQQX 2007
- ARDX 2007
- Country
- QQQX United States
- ARDX United States
- Employees
- QQQX N/A
- ARDX N/A
- Industry
- QQQX Finance Companies
- ARDX Biotechnology: Pharmaceutical Preparations
- Sector
- QQQX Finance
- ARDX Health Care
- Exchange
- QQQX Nasdaq
- ARDX Nasdaq
- Market Cap
- QQQX 1.2B
- ARDX 1.4B
- IPO Year
- QQQX N/A
- ARDX 2014
- Fundamental
- Price
- QQQX $25.76
- ARDX $5.12
- Analyst Decision
- QQQX
- ARDX Buy
- Analyst Count
- QQQX 0
- ARDX 7
- Target Price
- QQQX N/A
- ARDX $11.75
- AVG Volume (30 Days)
- QQQX 127.6K
- ARDX 5.8M
- Earning Date
- QQQX 01-01-0001
- ARDX 10-31-2024
- Dividend Yield
- QQQX 7.03%
- ARDX N/A
- EPS Growth
- QQQX N/A
- ARDX N/A
- EPS
- QQQX N/A
- ARDX N/A
- Revenue
- QQQX N/A
- ARDX $251,849,000.00
- Revenue This Year
- QQQX N/A
- ARDX $167.24
- Revenue Next Year
- QQQX N/A
- ARDX $18.93
- P/E Ratio
- QQQX N/A
- ARDX N/A
- Revenue Growth
- QQQX N/A
- ARDX 87.57
- 52 Week Low
- QQQX $20.27
- ARDX $4.06
- 52 Week High
- QQQX $25.99
- ARDX $10.13
- Technical
- Relative Strength Index (RSI)
- QQQX 52.47
- ARDX 44.65
- Support Level
- QQQX $25.60
- ARDX $4.63
- Resistance Level
- QQQX $26.33
- ARDX $6.53
- Average True Range (ATR)
- QQQX 0.28
- ARDX 0.44
- MACD
- QQQX -0.04
- ARDX -0.03
- Stochastic Oscillator
- QQQX 59.86
- ARDX 35.59
About QQQX Nuveen NASDAQ 100 Dynamic Overwrite Fund Shares of Beneficial Interest
Nuveen NASDAQ 100 Dynamic Overwrite Fund is a closed-end management investment company. Its investment objective is to seek attractive total return with less volatility than the Nasdaq 100 Index. Under normal circumstances, the Fund will invest at least 80% of its Assets in an equity portfolio made up of securities comprising the Nasdaq 100 Index (or securities that have economic characteristics that are similar to those securities comprising the Nasdaq 100 Index) that seeks to substantially replicate price movements of the Nasdaq 100 Index and is designed to support the Fund's option strategy.
About ARDX Ardelyx Inc.
Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.